162 related articles for article (PubMed ID: 22529895)
1. Chromogranin A (CgA) as poor prognostic factor in patients with small cell carcinoma of the cervix: results of a retrospective study of 293 patients.
Liao LM; Zhang X; Ren YF; Sun XY; Di N; Zhou N; Pan RK; Ma SH; Zhou LX
PLoS One; 2012; 7(4):e33674. PubMed ID: 22529895
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients.
Huang L; Liao LM; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M
BMC Cancer; 2014 Feb; 14():140. PubMed ID: 24575810
[TBL] [Abstract][Full Text] [Related]
3. The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
Kawamura M; Koide Y; Murai T; Ishihara S; Takase Y; Murao T; Okazaki D; Yamaguchi T; Uchiyama K; Itoh Y; Kodaira T; Shibamoto Y; Mizuno M; Kikkawa F; Naganawa S
BMC Cancer; 2021 Sep; 21(1):1046. PubMed ID: 34556082
[TBL] [Abstract][Full Text] [Related]
4. A clinicopathological aspect of primary small-cell carcinoma of the uterine cervix: a single-centre study of 25 cases.
Li JD; Zhuang Y; Li YF; Feng YL; Hou JH; Chen L; Zhu AN; Wu QL; Yun JP
J Clin Pathol; 2011 Dec; 64(12):1102-7. PubMed ID: 21965825
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological analysis of nine cases of small cell carcinoma of the uterine cervix].
Deng GH; Zhang X; Wu LY
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):199-202. PubMed ID: 20450588
[TBL] [Abstract][Full Text] [Related]
6. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
Feng M; Zou J; Zhang Y; Sun L
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
[No Abstract] [Full Text] [Related]
7. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
[TBL] [Abstract][Full Text] [Related]
8. Postoperative adjuvant radiation improves local control in surgically treated FIGO stage I-II small cell carcinoma of the cervix.
Shen T; Jiang YH; Zou YY; Qiu FF; Qiu XS; You KY
Radiat Oncol; 2019 Nov; 14(1):203. PubMed ID: 31722727
[TBL] [Abstract][Full Text] [Related]
9. Prognostic risk factors for small cell carcinoma of the cervix and impact of platinum-based neoadjuvant chemotherapy.
Li X; Yang R; Jia Y; Zhou J; Ma D; Li S
Int J Gynaecol Obstet; 2015 Jul; 130(1):31-5. PubMed ID: 25890393
[TBL] [Abstract][Full Text] [Related]
10. The local treatment modalities in FIGO stage I-II small-cell carcinoma of the cervix are determined by disease stage and lymph node status.
Zhou J; Yang HY; Wu SG; He ZY; Lin HX; Sun JY; Li Q; Guo ZW
Cancer Med; 2016 Jun; 5(6):1108-15. PubMed ID: 26990881
[TBL] [Abstract][Full Text] [Related]
11. Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus.
Ku JW; Zhang DY; Song X; Li XM; Zhao XK; Lv S; Hu SJ; Cheng R; Zhou FY; Wu HF; Wang LD
Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575250
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix.
Huang L; Lin JX; Yu YH; Zhang MY; Wang HY; Zheng M
PLoS One; 2012; 7(3):e33762. PubMed ID: 22438992
[TBL] [Abstract][Full Text] [Related]
13. Predictors of outcome in small cell carcinoma of the cervix--a case series.
Straughn JM; Richter HE; Conner MG; Meleth S; Barnes MN
Gynecol Oncol; 2001 Nov; 83(2):216-20. PubMed ID: 11606074
[TBL] [Abstract][Full Text] [Related]
14. Small cell carcinoma of the uterine cervix: a multi-institutional experience.
Li J; Ouyang Y; Tao Y; Wang L; Li M; Gao L; Cao X
Int J Gynecol Cancer; 2020 Feb; 30(2):174-180. PubMed ID: 31792086
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
17. Influence of clinicopathological characteristics and comprehensive treatment models on the prognosis of small cell carcinoma of the cervix: A systematic review and meta-analysis.
Zhang Q; Xiong Y; Ye J; Zhang L; Li L
PLoS One; 2018; 13(4):e0192784. PubMed ID: 29641578
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Factors and Local Treatment Modalities of Small-Cell Carcinoma of the Cervix: An Analysis According to the International Federation of Gynecology and Obstetrics Stage.
Huang R; Gan Q; Cheng J
Cancer Manag Res; 2020; 12():3445-3456. PubMed ID: 32523375
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and treatment comparison in small cell neuroendocrine cervical carcinoma.
Yin ZM; Yu AJ; Wu MJ; Zhu JQ; Zhang X; Chen JH; Yuan SH; Yu H
Eur J Gynaecol Oncol; 2014; 35(3):259-63. PubMed ID: 24984537
[TBL] [Abstract][Full Text] [Related]
20. Trends and predictors of survival for small cell carcinoma of the cervix uteri: A SEER population study.
Song T; Wan Q; Fang M; Zhan W; Xu H; Shou H
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():35-41. PubMed ID: 32768799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
